Essepna 1.2 g (Arginine SOLUTION) 1.2 G

ESSEPNA 1.2 G is an intravenous arginine solution used for medical purposes. This product, manufactured by Fresenius Kabi Canada Ltd., is designed to support various therapeutic needs.

Strength

1.2 G

Manufacturer / TM Owner

FRESENIUS KABI CANADA LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ESSEPNA 1.2 G is primarily used to provide arginine, an amino acid, intravenously. Arginine is often utilized in medical settings to support various physiological functions. Patients may wonder, 'What is arginine used for?' It can play a role in wound healing, immune function, and other metabolic processes.

Side Effects

When administered intravenously, ESSEPNA 1.2 G delivers arginine directly into the bloodstream. This can help maintain adequate levels of arginine in the body, which is essential for various biochemical processes. Patients may experience improved metabolic function and support for immune responses.

Precautions & Warnings

ESSEPNA 1.2 G should be handled with care, following proper medical guidelines. It is important to ensure that the solution is administered by a healthcare professional to avoid any potential complications. Always check the packaging for any specific instructions or warnings.

Avoid Interactions

ESSEPNA 1.2 G may interact with certain medications or substances. It is advisable to consult with a healthcare provider before use, especially if you are taking other medications or have underlying health conditions. Be aware of potential interactions with alcohol or other intravenous treatments.

Frequently Asked Questions

ESSEPNA 1.2 G is used to provide arginine intravenously, supporting various physiological functions such as wound healing and immune response.

ESSEPNA 1.2 G is administered intravenously, meaning it is delivered directly into the bloodstream through a vein.

The common effects of ESSEPNA 1.2 G include supporting metabolic processes and immune function by providing arginine directly into the bloodstream.

Yes, ESSEPNA 1.2 G should be administered by a healthcare professional to ensure safety and effectiveness.

ESSEPNA 1.2 G may interact with certain medications or substances, so it is important to consult with a healthcare provider before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.